跳至主要内容
临床试验/ACTRN12621001202853
ACTRN12621001202853进行中(未招募)未知

Efficacy of COVID-19 Vaccination in People with Follicular Lymphoma and Waldenström Macroglobulinaemia – A Prospective Cohort Study

Concord Repatriation General Hospital0 个研究点目标入组 85 人开始时间: 2021年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Patient with low grade FL treated with immunochemotherapy
  • 2. Patients with FL who are treatment-naïve.
  • 3. Patients with WM currently on treatment with a BTKi
  • 4. Patients with WM during or following treatment with standard immunochemotherapy
  • 5. Patients with WM who are treatment-naïve.
  • 6. A group of healthy volunteers who are controls

排除标准

  • 1. Patients with additional medical co-morbidities and/or medications that compromise their immune function (e.g. inflammatory bowel disease, rheumatoid arthritis, SLE, HIV, high dose prednisolone for reasons other than lymphoma treatment). If there is any doubt, the final decision will rest with the PI.
  • 2. Those not wishing to consent

研究者

相似试验